Evidence map›Paper›PMID 40756175›Full record

ArticleBMJ public health2025

To whom should we prescribe doxy-PEP? A retrospective review of public health surveillance data for bacterial STI diagnoses among gay, bisexual, and other men who have sex with men in Ottawa, Canada.

Patrick O'Byrne, Dara Spatz Friedman, Lauren Orser

Abstract read
In one paragraph

Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Patrick O'ByrneSchool of Nursing, University of Ottawa, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0002-0587-1409
Dara Spatz FriedmanOttawa Public Health, Ottawa, Ontario, Canada.
Lauren OrserSchool of Nursing, University of Ottawa, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Increases in bacterial sexually transmitted infections (bac-STIs), such as gonorrhoea, chlamydia and syphilis, have affected gay, bisexual, and other men who have sex with men (gbMSM). A new strategy to prevent bac-STIs involves giving doxycycline as postexposure prophylaxis (doxy-PEP), and research shows that this intervention can prevent chlamydia and syphilis by 70% and gonorrhoea by 33%-50%. Consequently, the US CDC released guidelines in 2024 recommending doxy-PEP for gbMSM with ≥1 bacterial STI diagnosis in the previous 12 months. Methods: We reviewed public health STI surveillance data between 1 January 2021 and 31 December 2024 for gbMSM in Ottawa, Canada, and analysed the number of infections and episodes of infections per person. We estimated the number of individuals who would need doxy-PEP to prevent a single bac-STI episode. Results: During the study period, 1819 unique gbMSM experienced 2834 positive bac-STI testing episodes (PTE), during which 3114 bac-STIs were diagnosed. Consistently, three-quarters of gbMSM did not have a subsequent infection, whether they were diagnosed with 1 infection, 2 infections or ≥3. Considering the average effectiveness of doxy-PEP in this study population, the average number needed to treat (NNT) if doxy-PEP were prescribed to all gbMSM to prevent a first PTE would have been 60. The NNT among those with their first PTE to prevent a second PTE was 8; among those with their second, the NNT was 7. Conclusions: Based on these data, and in alignment with the CDC guidelines, we conclude that doxy-PEP would likely have the most balanced population-level bac-STI prevention effect if given to gbMSM with ≥1 bac-STI diagnosis within the preceding 12 months. Providing doxy-PEP to all gbMSM would likely result in an overuse of antibiotics, and providing doxy-PEP only after a second PTE would result in fewer infections averted for the same proportion treated.

Indexed as

Communicable Disease ControlDisease Transmission, InfectiousPublic HealthSexually Transmitted Diseases

Identifiers

PMID40756175
PMCPMC12314957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.